Hearings, Meetings, Proceedings, etc.: Endocrinologic and Metabolic Drugs Advisory Committee; New Drug Application 210934 for Sotagliflozin Oral Tablet

TitleHearings, Meetings, Proceedings, etc.: Endocrinologic and Metabolic Drugs Advisory Committee; New Drug Application 210934 for Sotagliflozin Oral Tablet
ToC Doc Endocrinologic and Metabolic Drugs Advisory Committee; New Drug Application 210934 for Sotagliflozin Oral Tablet
Docket Number2024-22570
Type Notice
Subject Hearings, Meetings, Proceedings, etc.:
Endocrinologic and Metabolic Drugs Advisory Committee; New Drug Application 210934 for Sotagliflozin Oral Tablet
Publication Date2024-10-02
Last Updated Date 2024-10-01 08:37:58 -0400
Last Public Inspection2024-10-01
Filed At2024-10-01T08:45:00.000-04:00
PDF 2024-22570_PI.pdf (109314 bytes)
Download TXT / HTML / JSON
Number of Pages 6
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021